Stay updated with breaking news from Controlled Equity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
10.08.2022 - Enrollment continues in RECONNECT, a confirmatory pivotal Phase 3 trial of Zygel in patients with Fragile X syndrome (FXS); topline results expected second-half 2023 Announced positive topline results from Phase 2 trial of Zygel in patients with ...
Pilot Program Has Processed 13 Metric Tonnes of Battery GraphiteFeasibility Study Underway with Samuel EngineeringExploration and Development Drill Program Underway at Coosa Graphite DepositCENTENNIAL, Colo.--(BUSINESS WIRE)--$WWR--Westwater Resources, Inc. (NYSE American: WWR), an explorer and developer of U.S. mineral resources essential for batteries for energy storage,
Zynerba Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Highlights - read this article along with other careers information, tips and advice on BioSpace
Seabridge Gold Inc.: Seabridge Gold Announces Agreement for At-The-Market Offering Toronto, Ontario--(Newsfile Corp. - January 22, 2021) - Seabridge Gold Inc. (TSX: SEA) (NYSE: SA) (the "Company" or "Seabridge") announces that it has entered into a Controlled Equity Offering SM Sales Agreement dated January 22, 2021 (the "Sales Agreement") with Cantor Fitzgerald & Co. (the "Lead Agent") and B. Riley Securities, Inc. (collectively with the Lead Agent, the "Agents"). Pursuant to the Sales Agreement, the Company will be entitled, at its discretion and from time-to-time during the term of the Sa...